A 2014 meta-analysis37 which examined 15 observational studies (6 prospective and 9 case-control studies), found a 5% reduction in overall breast cancer risk for 3 μg/ml increments in adiponectin, but no significant associations in post- or premenopausal women examined separately. Here, ADIPOQ is linked to breast carcinoma.